Oxycodone drugs market to reach $8.07 billion by 2030 at 6.1% cagr, driven by rising burden of orthopedic disorders and chronic pain conditions.
Read More
Ovulation inducing drugs market to reach $6.62 billion by 2030 at 7.3% cagr, driven by increasing prevalence of women’s infertility globally.
Read More
Over the counter vitamins and minerals dietary supplements market to reach $73.4 billion by 2030 at 6.1% cagr, driven by growing awareness of preventive healthcare.
Read More
Over the counter sleep aids medication market to reach $33.15 billion by 2030 at 7.8% cagr, driven by rising prevalence of insomnia and growing stress levels.
Read More
Over the counter probiotics supplements market to reach $12.1 billion by 2030 at 11.0% cagr, driven by increasing prevalence of digestive disorders worldwide.
Read More
Over the counter diet products market to reach $213.26 billion by 2030 at 8.5% cagr, driven by rising health consciousness and proactive weight management trends.
Read More
Over the counter artificial tears market to reach $6.53 billion by 2030 at 5.7% cagr, driven by increasing prevalence of eye diseases and vision impairment.
Read More
Over the counter analgesics market to reach $45.91 billion by 2030 at 6.0% cagr, driven by growing consumer preference for self-medication.
Read More
Over the counter topical drugs market to reach $101.09 billion by 2030 at 9.7% cagr, driven by increasing incidence of skin cancer and related conditions.
Read More
Over the counter drugs market to reach $216.97 billion by 2030 at 5.3% cagr, driven by rising prevalence of lifestyle-related health issues globally.
Read More